A Detailed Analysis of the At-Home Molecular Testing Market Based on Rising Consumer Awareness About Personalized Medicine, Advent of Molecular Diagnostic Technologies, and the Convenience and Privacy in Case of Genetic and Health-related Testing
Industry: Healthcare
Published Date: January-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 221
Report ID: PMRREP33685
1. Executive Summary
1.1. Global At-home Molecular Testing Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. At-home Molecular Testing Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global At-home Molecular Testing Market Outlook: Product
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
3.3.3.1. Cassettes
3.3.3.2. Strips
3.3.3.3. Test Panels
3.3.3.4. Dip Cards
3.3.3.5. Midstreams
3.3.3.6. Others
3.4. Market Attractiveness Analysis: Product
3.5. Global At-home Molecular Testing Market Outlook: Test Type
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Test Type, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
3.5.3.1. Pregnancy Tests
3.5.3.2. HIV Tests
3.5.3.3. Diabetes
3.5.3.4. Infectious Diseases
3.5.3.5. Glucose Tests
3.5.3.6. Ovulation Predictor Tests
3.5.3.7. Drug Abuse Tests
3.5.3.8. Others
3.6. Market Attractiveness Analysis: Test Type
3.7. Global At-home Molecular Testing Market Outlook: Sample Type
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Sample Type, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
3.7.3.1. Urine
3.7.3.2. Blood
3.7.3.3. Saliva
3.7.3.4. Others
3.8. Market Attractiveness Analysis: Sample Type
3.9. Global At-home Molecular Testing Market Outlook: Distribution Channel
3.9.1. Introduction / Key Findings
3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Distribution Channel, 2018 - 2022
3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
3.9.3.1. Retail Pharmacies
3.9.3.2. Drug Stores
3.9.3.3. Supermarkets/Hypermarkets
3.9.3.4. Online Pharmacies
3.10. Market Attractiveness Analysis: Distribution Channel
4. Global At-home Molecular Testing Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Product
5.3.3. By Test Type
5.3.4. By Sample Type
5.3.5. By Distribution Channel
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
5.5.1. Cassettes
5.5.2. Strips
5.5.3. Test Panels
5.5.4. Dip Cards
5.5.5. Midstreams
5.5.6. Others
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
5.6.1. Pregnancy Tests
5.6.2. HIV Tests
5.6.3. Diabetes
5.6.4. Infectious Diseases
5.6.5. Glucose Tests
5.6.6. Ovulation Predictor Tests
5.6.7. Drug Abuse Tests
5.6.8. Others
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
5.7.1. Urine
5.7.2. Blood
5.7.3. Saliva
5.7.4. Others
5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
5.8.1. Retail Pharmacies
5.8.2. Drug Stores
5.8.3. Supermarkets/Hypermarkets
5.8.4. Online Pharmacies
5.9. Market Attractiveness Analysis
6. Europe At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Product
6.3.3. By Test Type
6.3.4. By Sample Type
6.3.5. By Distribution Channel
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
6.5.1. Cassettes
6.5.2. Strips
6.5.3. Test Panels
6.5.4. Dip Cards
6.5.5. Midstreams
6.5.6. Others
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
6.6.1. Pregnancy Tests
6.6.2. HIV Tests
6.6.3. Diabetes
6.6.4. Infectious Diseases
6.6.5. Glucose Tests
6.6.6. Ovulation Predictor Tests
6.6.7. Drug Abuse Tests
6.6.8. Others
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
6.7.1. Urine
6.7.2. Blood
6.7.3. Saliva
6.7.4. Others
6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
6.8.1. Retail Pharmacies
6.8.2. Drug Stores
6.8.3. Supermarkets/Hypermarkets
6.8.4. Online Pharmacies
6.9. Market Attractiveness Analysis
7. East Asia At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Product
7.3.3. By Test Type
7.3.4. By Sample Type
7.3.5. By Distribution Channel
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
7.5.1. Cassettes
7.5.2. Strips
7.5.3. Test Panels
7.5.4. Dip Cards
7.5.5. Midstreams
7.5.6. Others
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
7.6.1. Pregnancy Tests
7.6.2. HIV Tests
7.6.3. Diabetes
7.6.4. Infectious Diseases
7.6.5. Glucose Tests
7.6.6. Ovulation Predictor Tests
7.6.7. Drug Abuse Tests
7.6.8. Others
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
7.7.1. Urine
7.7.2. Blood
7.7.3. Saliva
7.7.4. Others
7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
7.8.1. Retail Pharmacies
7.8.2. Drug Stores
7.8.3. Supermarkets/Hypermarkets
7.8.4. Online Pharmacies
7.9. Market Attractiveness Analysis
8. South Asia & Oceania At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Product
8.3.3. By Test Type
8.3.4. By Sample Type
8.3.5. By Distribution Channel
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
8.5.1. Cassettes
8.5.2. Strips
8.5.3. Test Panels
8.5.4. Dip Cards
8.5.5. Midstreams
8.5.6. Others
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
8.6.1. Pregnancy Tests
8.6.2. HIV Tests
8.6.3. Diabetes
8.6.4. Infectious Diseases
8.6.5. Glucose Tests
8.6.6. Ovulation Predictor Tests
8.6.7. Drug Abuse Tests
8.6.8. Others
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
8.7.1. Urine
8.7.2. Blood
8.7.3. Saliva
8.7.4. Others
8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
8.8.1. Retail Pharmacies
8.8.2. Drug Stores
8.8.3. Supermarkets/Hypermarkets
8.8.4. Online Pharmacies
8.9. Market Attractiveness Analysis
9. Latin America At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Product
9.3.3. By Test Type
9.3.4. By Sample Type
9.3.5. By Distribution Channel
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
9.5.1. Cassettes
9.5.2. Strips
9.5.3. Test Panels
9.5.4. Dip Cards
9.5.5. Midstreams
9.5.6. Others
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
9.6.1. Pregnancy Tests
9.6.2. HIV Tests
9.6.3. Diabetes
9.6.4. Infectious Diseases
9.6.5. Glucose Tests
9.6.6. Ovulation Predictor Tests
9.6.7. Drug Abuse Tests
9.6.8. Others
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
9.7.1. Urine
9.7.2. Blood
9.7.3. Saliva
9.7.4. Others
9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
9.8.1. Retail Pharmacies
9.8.2. Drug Stores
9.8.3. Supermarkets/Hypermarkets
9.8.4. Online Pharmacies
9.9. Market Attractiveness Analysis
10. Middle East & Africa At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Product
10.3.3. By Test Type
10.3.4. By Sample Type
10.3.5. By Distribution Channel
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
10.5.1. Cassettes
10.5.2. Strips
10.5.3. Test Panels
10.5.4. Dip Cards
10.5.5. Midstreams
10.5.6. Others
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
10.6.1. Pregnancy Tests
10.6.2. HIV Tests
10.6.3. Diabetes
10.6.4. Infectious Diseases
10.6.5. Glucose Tests
10.6.6. Ovulation Predictor Tests
10.6.7. Drug Abuse Tests
10.6.8. Others
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
10.7.1. Urine
10.7.2. Blood
10.7.3. Saliva
10.7.4. Others
10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
10.8.1. Retail Pharmacies
10.8.2. Drug Stores
10.8.3. Supermarkets/Hypermarkets
10.8.4. Online Pharmacies
10.9. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Abbott
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. ACON Laboratories, Inc.
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Rapikit
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Becton and Dickinson
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Cardinal Health
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. B. Braun Melsungen AG
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Piramal Enterprises Ltd.
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Siemens Healthcare GmbH
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Quidel Corporation
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. Bionime Corporation
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. SA Scientific
11.3.11.1. Overview
11.3.11.2. Segments and Product
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
11.3.12. ARKRAY USA, Inc.
11.3.12.1. Overview
11.3.12.2. Segments and Product
11.3.12.3. Key Financials
11.3.12.4. Market Developments
11.3.12.5. Market Strategy
11.3.13. Nova Biomedical
11.3.13.1. Overview
11.3.13.2. Segments and Product
11.3.13.3. Key Financials
11.3.13.4. Market Developments
11.3.13.5. Market Strategy
11.3.14. AdvaCare Pharma
11.3.14.1. Overview
11.3.14.2. Segments and Product
11.3.14.3. Key Financials
11.3.14.4. Market Developments
11.3.14.5. Market Strategy
11.3.15. AccuBioTech Co., Ltd.
11.3.15.1. Overview
11.3.15.2. Segments and Product
11.3.15.3. Key Financials
11.3.15.4. Market Developments
11.3.15.5. Market Strategy
11.3.16. Atlas Medical UK
11.3.16.1. Overview
11.3.16.2. Segments and Product
11.3.16.3. Key Financials
11.3.16.4. Market Developments
11.3.16.5. Market Strategy
11.3.17. TaiDoc Technology Corporation
11.3.17.1. Overview
11.3.17.2. Segments and Product
11.3.17.3. Key Financials
11.3.17.4. Market Developments
11.3.17.5. Market Strategy
11.3.18. Drägerwerk AG & Co. KGaA
11.3.18.1. Overview
11.3.18.2. Segments and Product
11.3.18.3. Key Financials
11.3.18.4. Market Developments
11.3.18.5. Market Strategy
11.3.19. F. Hoffmann-La Roche Ltd
11.3.19.1. Overview
11.3.19.2. Segments and Product
11.3.19.3. Key Financials
11.3.19.4. Market Developments
11.3.19.5. Market Strategy
11.3.20. Sensing Self
11.3.20.1. Overview
11.3.20.2. Segments and Product
11.3.20.3. Key Financials
11.3.20.4. Market Developments
11.3.20.5. Market Strategy
11.3.21. PTE. Ltd
11.3.21.1. Overview
11.3.21.2. Segments and Product
11.3.21.3. Key Financials
11.3.21.4. Market Developments
11.3.21.5. Market Strategy
11.3.22. Atomo Diagnostics
11.3.22.1. Overview
11.3.22.2. Segments and Product
11.3.22.3. Key Financials
11.3.22.4. Market Developments
11.3.22.5. Market Strategy
11.3.23. Mankind Pharma
11.3.23.1. Overview
11.3.23.2. Segments and Product
11.3.23.3. Key Financials
11.3.23.4. Market Developments
11.3.23.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
